Navigation Links
First Boston Pharma, LLC Acquires NutraMax Products, Inc.
Date:5/13/2009

GLOUCESTER, Mass., May 13 /PRNewswire/ -- First Boston Pharma announces the acquisition of NutraMax, Products, Inc., a contract manufacturer of solid dose and soft chew pharmaceuticals and supplements. The company will now be known as First Boston Pharma, LLC.

Leading the First Boston Pharma organization is Mario Medri, one of the industry's foremost innovators in over-the-counter ("OTC") drugs and supplement formulations. With over 40 years of experience in the consumer packaging goods industry, Medri has developed a multitude of products in the OTC drug and supplements categories, as well as flavors, fragrances, confections, foods and cosmetics. He holds over 15 product and process patents. Medri's many contributions to the market include inventing soft chews as a vehicle for delivery of OTC drugs and supplements and developing new products and technologies for pectin/menthol cough drops, honey liquid center cough drops and liquid center throat lozenges.

"The acquisition by Mario and the First Boston Pharma Group will propel the company further and faster along the trajectory we are on, particularly with designer products for pharmaceuticals and supplement markets," says Rodney Plunkett, Executive Vice President of First Boston Pharma. "To have the industry's foremost innovator leading First Boston Pharma into the future is an exciting prospect for us and for our customers," adds Plunkett.

The acquisition of NutraMax by First Boston Pharma will provide the necessary resources for the company to pursue its strategy of innovation in the over-the-counter drugs and supplements categories. The company will drive its growth strategy though investment in additional R&D, and in unique production capabilities. "One of our key strategies is to move to a supply base integrity model, which gives our customers the differentiated products they need, when they want them," says Medri.

About First Boston Pharma, LLC:

First Boston Pharma, LLC is a contract manufacturer of solid dose, soft chew, liquid, tablet and chewing gum based pharmaceuticals and supplements servicing branded companies and retailer private label products. The company provides turnkey services to customers wishing to introduce new products from product ideation to R&D, product development to production. Headquartered in Gloucester, MA, First Boston Pharma has an additional facility in Brockton, MA. All facilities are FDA registered drug manufacturing sites, and also cGMP and DSHEA compliant. For more information, visit www.Firstbostonpharma.com

LINKS

Mario Medri mmedri@1stbp.com

Rodney Plunkett rplunkett@1stbp.com

First Boston Pharma, LLC www.firstbostonpharma.com


'/>"/>
SOURCE First Boston Pharma, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Super Lice Repelled by All-Natural Products First Ever Independent Study Shows
2. AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure
3. China Medicine Announces First Quarter 2009 Results
4. Amilpar - Revenue Increases 13.4% and Medical Loss Ratio Falls in the First Quarter 2009
5. Pharmos Corporation Reports 2009 First Quarter Results
6. Pregis Announces First Quarter 2009 Financial Results
7. Access to care leads Americans priorities in first-ever public study of health value
8. Access to Care Leads Americans Priorities in First-Ever Public Study of Health Value
9. The Nielsen Company Launches First-Ever CLIO Healthcare Awards Acknowledging Creative Excellence in Healthcare Communications
10. Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook
11. Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... ... 2017 , ... KICKICO , a protocol built on Ethereum for more ... catastrophic issues within funding campaigns. KICKICO developers are testing the platform, which will launch ... raising of funds through the power of many - has been around for about ...
(Date:6/25/2017)... ... ... lyric music video in Final Cut Pro X with ProLyric from Pixel Film Studios. Users ... to any song. ProLyric flies in the text for each section and it hovers around ... for optimal control. ProLyric makes editing any music video or text-based production easier than ever. ...
(Date:6/25/2017)... , ... June 25, 2017 , ... CareSet Labs released ... in New Orleans. This is a new, greatly improved version of the Doctor Referral ... (FOIA) requests by Fred Trotter and subsequently called the the “Doctor Referral Dataset” as ...
(Date:6/24/2017)... ... June 24, 2017 , ... ... testing for medications in select Florida and Texas doctors' offices and clinics. This ... new application of genetic testing recognizes the role genes play in determining an ...
(Date:6/24/2017)... , ... June 24, 2017 , ... The weather is ... time outdoors. Home and business owners should be aware that the summer months provide ... In fact, mechanical locks and keys can be negatively affected from direct exposure to ...
Breaking Medicine News(10 mins):
(Date:5/24/2017)... Va. , May 24, 2017  ivWatch ... Original Equipment Manufacturer (OEM) Board to enable seamless ... with patient monitoring systems, infusion pumps and other ... OEMs will be able to help health care ... and reduced risks related to IV therapy. ...
(Date:5/22/2017)... Fla. , May 22, 2017  As ... as a whole continue to make the revolutionary ... becomes increasingly important for ensuring positive patient outcomes ... industry stakeholders are shifting focus away from clinical ... and effects of long-term specialty drug therapy utilization ...
(Date:5/15/2017)... -- Amy Baxter MD, chief executive officer and founder of ... was awarded a 2017 Top 40 Healthcare Transformer designation ... the MM&M Top 40 Healthcare Transformers dinner and awards ... May 10, 2017. The dinner followed a full-day conference ... pill."  "Innovation goes beyond invention," noted Baxter ...
Breaking Medicine Technology: